These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 24642015)

  • 41. Natural killer cells as indispensable players and therapeutic targets in autoimmunity.
    Shi FD; Zhou Q
    Autoimmunity; 2011 Feb; 44(1):3-10. PubMed ID: 20701455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of innate and adaptive immune responses on atherosclerosis.
    Witztum JL; Lichtman AH
    Annu Rev Pathol; 2014; 9():73-102. PubMed ID: 23937439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. From autoinflammation to autoimmunity: old and recent findings.
    Caso F; Costa L; Nucera V; Barilaro G; Masala IF; Talotta R; Caso P; Scarpa R; Sarzi-Puttini P; Atzeni F
    Clin Rheumatol; 2018 Sep; 37(9):2305-2321. PubMed ID: 30014358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fueling autoimmunity: type I interferon in autoimmune diseases.
    Di Domizio J; Cao W
    Expert Rev Clin Immunol; 2013 Mar; 9(3):201-10. PubMed ID: 23445195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammation in atherosclerosis: transition from theory to practice.
    Libby P; Okamoto Y; Rocha VZ; Folco E
    Circ J; 2010 Feb; 74(2):213-20. PubMed ID: 20065609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting autoimmunity: strategies and tactics.
    Masuda ES; Payan DG
    Drug Discov Today; 2014 Aug; 19(8):1193-4. PubMed ID: 24886764
    [No Abstract]   [Full Text] [Related]  

  • 47. Infections as triggers of flares in systemic autoimmune diseases: novel innate immunity mechanisms.
    Torres-Aguilar H; Sosa-Luis SA; Aguilar-Ruiz SR
    Curr Opin Rheumatol; 2019 Sep; 31(5):525-531. PubMed ID: 31135383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxidation-specific epitopes are major targets of innate immunity in atherothrombosis.
    Bartolini Gritti B; Binder CJ
    Hamostaseologie; 2016 May; 36(2):89-96. PubMed ID: 25682990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammation and immune system contribution to the etiology of atherosclerosis: mechanisms and methods of assessment.
    Salisbury D; Bronas U
    Nurs Res; 2014; 63(5):375-85. PubMed ID: 25171563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis.
    Dart ML; Jankowska-Gan E; Huang G; Roenneburg DA; Keller MR; Torrealba JR; Rhoads A; Kim B; Bobadilla JL; Haynes LD; Wilkes DS; Burlingham WJ; Greenspan DS
    Circ Res; 2010 Oct; 107(9):1106-16. PubMed ID: 20814021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of oxidized low-density lipoproteins (ox-LDL) versus ox-LDL/beta2GPI complexes for the assessment of autoimmune-mediated atherosclerosis.
    Lopez LR; Buckner TR; Hurley BL; Kobayashi K; Matsuura E
    Ann N Y Acad Sci; 2007 Aug; 1109():303-10. PubMed ID: 17785319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trained Immunity: An Underlying Driver of Inflammatory Atherosclerosis.
    Zhong C; Yang X; Feng Y; Yu J
    Front Immunol; 2020; 11():284. PubMed ID: 32153588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of innate immunity in atherogenesis.
    Hartvigsen K; Chou MY; Hansen LF; Shaw PX; Tsimikas S; Binder CJ; Witztum JL
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S388-93. PubMed ID: 19106070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
    Shin JI; Lee KH; Joo YH; Lee JM; Jeon J; Jung HJ; Shin M; Cho S; Kim TH; Park S; Jeon BY; Jeong H; Lee K; Kang K; Oh M; Lee H; Lee S; Kwon Y; Oh GH; Kronbichler A
    J Autoimmun; 2019 Sep; 103():102299. PubMed ID: 31326231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role of TLR-dependent and independent pathways in autoimmunity].
    Kumagai Y; Akira S
    Nihon Rinsho; 2009 Mar; 67(3):487-93. PubMed ID: 19280921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of macrophage function in inflammation and atherosclerosis.
    Shibata N; Glass CK
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S277-81. PubMed ID: 18987388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis.
    Mohanta SK; Yin C; Peng L; Srikakulapu P; Bontha V; Hu D; Weih F; Weber C; Gerdes N; Habenicht AJ
    Circ Res; 2014 May; 114(11):1772-87. PubMed ID: 24855201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunologic basis for autoimmunity and the potential influences of xenobiotics.
    Kimber I; Dearman RJ
    Toxicol Lett; 2002 Feb; 127(1-3):77-81. PubMed ID: 12052644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.